{"name":"Veloce BioPharma LLC","slug":"veloce-biopharma-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"2014-ALC-919-US","genericName":"2014-ALC-919-US","slug":"2014-alc-919-us","indication":"Metastatic non-small cell lung cancer, PD-L1 positive","status":"phase_2"}]}],"pipeline":[{"name":"2014-ALC-919-US","genericName":"2014-ALC-919-US","slug":"2014-alc-919-us","phase":"phase_2","mechanism":"This drug targets the PD-1 receptor to modulate the immune response.","indications":["Metastatic non-small cell lung cancer, PD-L1 positive","Metastatic melanoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBYOXhTZWp2WkRxaExkZ2lSbDlCV3QzSUZ6RjFDUXRIakRYV01Vdkp3LTBlMlBpOWxOck1wbmNTTUJHbFZKSjk5NWU2STJKZXFTc05leTZhbEcwT0hyb0ZfcUJuQUQ0WHF2RnZ6WjNSano?oc=5","date":"2020-02-25","type":"regulatory","source":"Straits Research","summary":"Molluscum Contagiosum Market Size, Top Share, Demand And Report to 2033 - Straits Research","headline":"Molluscum Contagiosum Market Size, Top Share, Demand And Report to 2033","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}